BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36975484)

  • 1. Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population.
    Šafčák D; Dražilová S; Gazda J; Andrašina I; Adamcová-Selčanová S; Barila R; Mego M; Rác M; Skladaný Ľ; Žigrai M; Janičko M; Jarčuška P
    Curr Oncol; 2023 Mar; 30(3):3557-3570. PubMed ID: 36975484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.
    Tokushige K; Hyogo H; Nakajima T; Ono M; Kawaguchi T; Honda K; Eguchi Y; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Suzuki Y; Kogiso T; Karino Y; Munekage K; Kuromatsu R; Oeda S; Yanase M; Mori K; Ogawa Y; Seko Y; Takehara T; Itoh Y; Nakajima A; Kanemasa K; Nishino K; Masaki N; Takahashi H; Seike M; Torimura T; Saibara T; Toyota J; Chayama K; Hashimoto E
    J Gastroenterol; 2016 Jun; 51(6):586-96. PubMed ID: 26456168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
    Ahn SY; Kim SB; Song IH
    Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
    Tateishi R; Okanoue T; Fujiwara N; Okita K; Kiyosawa K; Omata M; Kumada H; Hayashi N; Koike K
    J Gastroenterol; 2015 Mar; 50(3):350-60. PubMed ID: 24929638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study.
    deLemos A; Patel M; Gawrieh S; Burney H; Dakhoul L; Miller E; Scanga A; Kettler C; Liu H; Roche P; Wattacheril J; Chalasani N
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00139. PubMed ID: 32352723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
    Ioannou GN; Green P; Kerr KF; Berry K
    J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
    Kim W; Jeong D; Chung J; Lee D; Joo S; Jang ES; Choi YJ; Yoon H; Shin CM; Park YS; Jeong SH; Kim N; Lee DH; Kim JW
    Sci Rep; 2019 Mar; 9(1):3236. PubMed ID: 30824851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.
    Hester CA; Rich NE; Singal AG; Yopp AC
    J Natl Compr Canc Netw; 2019 Apr; 17(4):322-329. PubMed ID: 30959469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
    Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
    Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis.
    Skladany L; Molcan P; Vnencakova J; Vrbova P; Kukla M; Laffers L; Koller T
    Can J Gastroenterol Hepatol; 2021; 2021():5576531. PubMed ID: 34095016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.
    Musunuri B; Shetty S; Bhat G; Udupa K; Pai A
    Indian J Gastroenterol; 2022 Apr; 41(2):127-134. PubMed ID: 35226292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
    Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
    Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.